Ernexa Therapeutics Inc. Increase (Decrease) in Due from Related Parties
Ernexa Therapeutics Inc. (ERNA) reported Increase (Decrease) in Due from Related Parties of -$750.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2026-08-06
- Ernexa Therapeutics Inc. increase (decrease) in due from related parties for the quarter ending 2026-06-30 was $0.00.
- Ernexa Therapeutics Inc. increase (decrease) in due from related parties for the quarter ending 2026-03-31 was -$750.00K.
- Ernexa Therapeutics Inc. increase (decrease) in due from related parties for fiscal 2025 was $750.00K.
| Period end | Increase (Decrease) in Due from Related Parties 3 month | Increase (Decrease) in Due from Related Parties 6 month | Increase (Decrease) in Due from Related Parties 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$750.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$750.00K 10-Q · filed 2026-05-11 | ||
| 2025-12-31 | $750.00K 10-K · filed 2026-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |